There were 1,801 press releases posted in the last 24 hours and 442,347 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
AzurRx BioPharma Presents Positive Secondary Endpoint Data in its Phase II MS1819-SD Chronic Pancreatitis Study at the 2019 Digestive Disease Week Conference

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image